Great staff extremely helpful and sympathetic to your needs
David Fritzman
5 years ago
WASHINGTON, D.C. — B. Braun Medical, in a joint venture with the FDA, announced that the company would voluntarily recall 22 lots of blood administration sets. The recalled sets were distributed across the United States and Canada. The recall initiative succeeds a discovery that determined that some of the devices will leak between the filters […]
Recall of Blood Sets
WASHINGTON, D.C. — B. Braun Medical, in a joint venture with the FDA, announced that the company would voluntarily recall 22 lots of blood administration sets. The recalled sets were distributed across the United States and Canada. The recall initiative succeeds a discovery that determined that some of the devices will leak between the filters and tubing. According to MedTechDive, any leaking from the device could cause a blood infection or delay the administration of treatment. B. Braun Medical proclaimed that the company is unaware of any deaths or serious injuries stemming from the defects in the blood administration sets.
The defect could be minimally invasive, or fatal, depending on the situation. B. Braun Medical indicated that a leak could delay treatment because the attending medical professional would have to connect a new device. In the worst-case scenario, the leak could permit microorganisms into the patient’s bloodstream, which might lead to a blood infection and sepsis. Sepsis could kill a person in some instances.
Braun Medical reported that the company asked medical professionals to stop using the recalled devices immediately. The company will repair or replace the recalled medical device without charge.
The FDA is monitoring the situation and has not assigned the recall to a particular Class, which would indicate the urgency of the problem.